
- GMP
About
uBriGene is a cell and gene therapy CDMO and CRO serving advanced therapy medicinal product developers. It supports development, manufacturing, QC testing, and regulatory filing for programs spanning early discovery through commercialization. It operates in the U.S., APAC, and China.
Services
GMP Cell Therapy
Manufactures CAR-T, CAR-NK, iPSC, MSC, and TIL therapies under GMP workflows with support for gene modification platforms.
GMP Lentivirus
Provides GMP lentiviral vector manufacturing using the LVV Turbo platform and qualified raw materials.
GMP sgRNA IVT
Produces GMP CRISPR guide RNA by in vitro transcription for gene-editing programs.
GMP RNA-LNP
Manufactures LNP-formulated mRNA, circRNA, and saRNA products for RNA therapeutics and vaccines.
GMP AAV
Provides GMP AAV manufacturing with qualified raw materials for vector production.
GMP Plasmid
Manufactures GMP plasmids for ATMP and vector production programs.
GMP Cell Banking
Manufactures and characterizes eukaryotic and prokaryotic cell banks under GMP.
GMP Oncolytic Virus
Provides oncolytic virus manufacturing services for vaccinia virus, adenovirus, and herpesvirus programs.
Aseptic Fill and Finish
Offers aseptic fill and finish services for advanced therapy products.
Regulatory Affairs Services
Supports regulatory strategy and filing for advanced therapy programs.
Plasmid Development and Production
Develops and produces plasmids for research and manufacturing use.
Viral Vector Development and Production
Develops and produces viral vectors for gene and cell therapy programs.
AAV Packaging
Provides AAV packaging services for gene therapy programs.
Lentivirus Packaging
Provides lentivirus packaging services for cell and gene therapy programs.
Adenovirus Packaging
Provides adenovirus packaging services for viral vector programs.
sgRNA IVT Production
Produces sgRNA by in vitro transcription for research and development programs.
RNA-LNP Development and Synthesis
Develops and synthesizes RNA-LNP products for therapeutic programs.
Analytical Development & Testing
Develops analytical methods and performs testing for plasmids, mRNA, cell therapy, and viral vectors.
Assays & in vitro testing
Viral Vector Storage & Stability Study
Provides storage and stability study services for viral vectors.
- Turnaround
- 03-week TIL production process · Three weeks
- What to send
- Qualified raw materials · Donor sourcing · Sample collection
- Minimums and prices
- 50% Off GMP Lentivirus Packaging Plasmids
Capabilities
- Assays and studies
- Cell therapy · LNP · Lentivirus · AAV · mRNA · Analytical development · CRISPR · QC release testing · Potency assays · Viability testing · Purity testing · Safety testing
1 more
Assay development - Scale and capacity
- 50 GMP production lines · Five GMP manufacturing sites · Six centers of excellence · More than 150 GMP batches successfully delivered · 100+ GMP CAR-T batches · 60+ batches of GMP lentiviral vector production · Up to 200L · Over 10 successful GMP TIL batches
- Therapeutic areas
- Immunotherapy
Instruments and platforms
- Closed automated system
- Fully closed downstream purification process
- QbD platform
Modalities and species
- Modalities
- mRNA · Viral vector · Cell therapy · Gene editing · Vaccine · Plasmid DNA · LNP / formulation
- Species and models
- Eukaryotic cell banks · Prokaryotic cell banks · 293TH suspension cell line
Certifications
As the company states them, with the certificate or registry record where there is one.
FDA registrationSelf-reported
GMPSelf-reported
Company
- Type
- CRDMO
Locations
- Address
- 20400 Century Blvd, Suite 125, Germantown, MD 20874 Canada
- Sites
- Germantown, United States · Richmond, Canada · Suzhou, China
- Serves
- US, APAC, EU
Contacts
- General enquiry
- info@ubrigene.com on their site
- General enquiry
- contact@ubrigene.com on their site
Public records
- FDA drug establishment registration
- 3032504289 · MANUFACTURE source
Similar labs
Work here? Claim this listing